<DOC>
	<DOCNO>NCT01617746</DOCNO>
	<brief_summary>The purpose study determine blockade endothelin 1 signal via endothelin receptor A use ambrisentan dual blockade ( A &amp; B ) via bosentan provide protection methacholine induce bronchoconstriction asthma .</brief_summary>
	<brief_title>Examination Bronchoprotective Effect Endothelin Receptor Blockade Asthma</brief_title>
	<detailed_description>Endothelin 1 may role development acute airway narrow asthma . Blockade endothelin system may thereby protect airway narrow . Two receptor exist endothelin 1 , Endothelin A &amp; B . Both blocked Bosentan , A receptor ambrisentan . Both medication currently use treatment pulmonary arterial hypertension . The investigator endeavour examine potential role endothelin 1 development airway narrow asthma blockade endothelin receptors A &amp; B use bosentan ambrisentan .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>1 . Physician diagnosis asthma confirm objectively airway hyperactivity methacholine ( determine ≥ 20 % drop FEV methacholine dose ≤ 8mg/ml βagonist withdrawal per ATS guideline ) 2 . Age range 1860 year 3 . FEV1 ≥ 60 % predict 4 . Duration asthma &gt; 6 month stable medication 4 week 5 . Prescribed compliant inhale corticosteroid maximum 2000mcg beclomethasone equivalent 6 . No history previous regular smoking current nonsmoker 1 . Unstable asthma ; define presence 1 follow event month prior study [ Emergency/'out hour ' visit GP asthma exacerbation ; GP visit patient home asthma exacerbation A &amp; E/hospital admission asthma exacerbation ] 2 . Treatment oral corticosteroid past month 3 . Need maintenance oral corticosteroid therapy 4 . Pregnancy plan become pregnant course study one month 5 . Excessive risk hepatotoxicity endothelin receptor antagonist ; Alcohol excess ( defined regular consumption government daily recommend limit ; currently define 28 unit per wk men , 21 unit per week woman ) Previous intravenous drug use Current know history liver disease ( exception Gilberts disease gallstone ) Chronic hepatitis ( either viral ( e.g . hepatitis B C ) autoimmune ) Bilirubin , alanine aminotransferase ( ALT ) asparate aminotransferase ( AST ) great upper limit normal screen 6 . Anaemia ( define haemoglobin lower reference range sex ) screen 7 . Renal failure ( define eGFR less 50 mL/minute/1.73 m2 ) screen 8 . Known HIV positivity 9 . History inability tolerate bosentan ambrisentan 10 . Significant medical condition asthma felt investigator preclude participation study . This could either patient best interest due potential significantly alter response medication hence alter power clinical trial ( example include ; significant heart failure ( NYHA grade IIIV ) , diabetes mellitus , bronchiectasis haematological malignancy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Endothelin</keyword>
	<keyword>Airway hyperreactivity</keyword>
</DOC>